Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care.

Al-Dourobi K, Laurent A, Deghayli L, Flahaut M, Abdel-Sayed P, Scaletta C, Michetti M, Waselle L, Simon JP, Ezzi OE, Raffoul W, Applegate LA, Hirt-Burri N, Roessingh ASB

Open source

DOI
10.3390/ph14030201
Published
2021 Feb 28
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph14030201,
  title = {Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care.},
  author = {Al-Dourobi K and Laurent A and Deghayli L and Flahaut M and Abdel-Sayed P and Scaletta C and Michetti M and Waselle L and Simon JP and Ezzi OE and Raffoul W and Applegate LA and Hirt-Burri N and Roessingh ASB},
  year = {2021},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph14030201},
  url = {https://doi.org/10.3390/ph14030201}
}

RIS

TY  - JOUR
TI  - Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care.
AU  - Al-Dourobi K
AU  - Laurent A
AU  - Deghayli L
AU  - Flahaut M
AU  - Abdel-Sayed P
AU  - Scaletta C
AU  - Michetti M
AU  - Waselle L
AU  - Simon JP
AU  - Ezzi OE
AU  - Raffoul W
AU  - Applegate LA
AU  - Hirt-Burri N
AU  - Roessingh ASB
PY  - 2021
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph14030201
UR  - https://doi.org/10.3390/ph14030201
ER  - 

APA

K, A., A, L., L, D., M, F., P, A., C, S., M, M., L, W., JP, S., OE, E., W, R., LA, A., N, H., & ASB, R. (2021). Retrospective Evaluation of Progenitor Biological Bandage Use: A Complementary and Safe Therapeutic Management Option for Prevention of Hypertrophic Scarring in Pediatric Burn Care.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph14030201

Source records